Welcome to our dedicated page for Breeze Holdings Acquisition news (Ticker: BREZ), a resource for investors and traders seeking the latest updates and insights on Breeze Holdings Acquisition stock.
Breeze Holdings Acquisition Corp. (historically associated with the symbol BREZ) generated news primarily as a special purpose acquisition company working to complete business combinations rather than as an operating business. Its press releases and SEC-referenced announcements focus on merger agreements, stockholder votes, listing status, and the transition of value to the operating companies it sought to combine with.
News coverage for Breeze includes multiple stages of proposed transactions. Earlier releases describe a business combination agreement with TV Ammo, Inc., also known as True Velocity, an advanced technology and composite manufacturing company focused on composite-cased ammunition, weapon systems, and suppressors. These items highlight the filing of a registration statement on Form S-4, conference participation, and transaction timelines.
Subsequent news documents a shift in strategy, including the termination of the TV Ammo business combination and Breeze’s stated intention to continue pursuing another target. Later, Breeze announced a definitive agreement to merge with YD Biopharma Limited, a clinical-stage biopharmaceutical company concentrating on cancer prevention medical diagnostics and exosome-based therapeutics. Follow-up releases detail patents and authorizations obtained by YD Biopharma, as well as the structure and expected listing of the combined company on the Nasdaq Capital Market.
More recent news reports that Breeze stockholders approved the business combination with YD Biopharma at a special meeting, with the combined company to be named YD Bio Limited and its ordinary shares expected to trade under the ticker “YDES.” Other items cover extensions of the SPAC’s business combination deadline, movement of its securities to OTCQX and OTCQB markets, and updates on trust account redemptions.
Investors and researchers using this news page can review the full sequence of announcements around BREZ, including transaction milestones, regulatory filings referenced in the releases, and the evolution from an initial SPAC listing to an approved merger with a biopharmaceutical company. This historical news record helps explain how Breeze’s capital and listing structure were used to support its chosen combination partners.
D-Orbit successfully launched its Spacelust mission on April 1, 2022, aboard SpaceX's Transporter-4. This marks the fifth launch of D-Orbit's ION Satellite Carrier, which deployed into a 500 km Sun-synchronous orbit. The mission included satellites for Kleos Space, enhancing their surveillance capabilities, and SPEL, focusing on plant growth studies in space. D-Orbit has four more launches planned for 2022, with the next ION mission scheduled for June. The company is also progressing with a merger with Breeze Holdings (NASDAQ: BREZ).
Breeze Holdings Acquisition Corp. (NASDAQ: BREZ) announced progress from D-Orbit, its merger partner, in a letter from CEO Luca Rossettini. Key highlights include advancing scheduled missions, with two launches slated for 2022, and a growing backlog now at €22.75 million, a 20% increase since December 2021. D-Orbit is enhancing its ION Satellite Carrier technology and aims to lead in in-orbit services, including debris removal. The merger is expected to finalize in Q2 or Q3 2022, positioning D-Orbit for rapid growth in the evolving space economy.
D-Orbit announced the launch of SPACELUST, its fifth mission with the ION Satellite Carrier, scheduled for April 2022 aboard SpaceX's Falcon 9 Transporter-4. The mission will deploy four satellites including Kleos Space's Patrol Mission, enhancing its data collection capacity by an additional 119 million km² daily. ION's versatility supports various payloads, including academic projects from the University of Chile. This mission continues D-Orbit's trend of rapid launches, with plans for another mission in June 2022.
D-Orbit has signed a contract with Spaceflight Inc. to launch the Kleos Patrol Mission (KSF2) satellites aboard the ION Satellite Carrier on the upcoming SpaceX Transporter-4 mission, scheduled for April 2022. Originally set for the Transporter-3 mission, the launch was rescheduled due to vehicle disembarkation. The four satellites will enhance operational capabilities, providing improved radio frequency geolocation services. D-Orbit's ION platform also reduces costs and time from launch to operation by up to 85% and 40%, respectively.
Summary not available.
Summary not available.
D-Orbit S.p.A., a leading space logistics firm, will go public via a merger with Breeze Holdings Acquisition Corp (NASDAQ: BREZ), valuing D-Orbit at approximately $1.28 billion. This partnership aims to leverage the expertise of The Charles F. Bolden Group to enhance D-Orbit's growth and service offerings. Notable technologies include the ION Satellite Carrier, which streamlines satellite deployment and reduces costs. With a projected revenue of $453 million by 2024 and an existing backlog of $21.5 million, D-Orbit is positioned to capitalize on the expanding space economy estimated to reach $1.4 trillion by 2030.
Breeze Holdings Acquisition Corp. (NASDAQ: BREZ) announced it received a notice from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1) due to a delayed filing of its Quarterly Report on Form 10-Q for Q3 2021. The Company filed a Form 12b-25 for the late filing and is revising its financial statements to classify all common stock as temporary equity following SEC guidance. The firm has 60 days to submit a compliance plan, which, if accepted, could extend its deadline up to 180 days, or until May 23, 2022.
Summary not available.
Summary not available.